Cargando…

Insights into the Therapeutic Potential of Glucocorticoid Receptor Modulators for Neurodegenerative Diseases

Glucocorticoids are crucial for stress-coping, resilience, and adaptation. However, if the stress hormones become dysregulated, the vulnerability to stress-related diseases is enhanced. In this brief review, we discuss the role of glucocorticoids in the pathogenesis of neurodegenerative disorders in...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Nicola, Alejandro F., Meyer, Maria, Guennoun, Rachida, Schumacher, Michael, Hunt, Hazel, Belanoff, Joseph, de Kloet, E. Ronald, Gonzalez Deniselle, Maria Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139912/ https://www.ncbi.nlm.nih.gov/pubmed/32244957 http://dx.doi.org/10.3390/ijms21062137

Ejemplares similares

Role of Sex Hormones on Brain Mitochondrial Function, with Special Reference to Aging and Neurodegenerative Diseases
por: Gaignard, Pauline, et al.
Publicado: (2017)

Context Modulates Outcome of Perinatal Glucocorticoid Action in the Brain
por: de Kloet, E. Ronald, et al.
Publicado: (2014)

Effects of Selective and Non-Selective Glucocorticoid Receptor II Antagonists on Rapid-Onset Diabetes in Young Rats
por: Beaudry, Jacqueline L., et al.
Publicado: (2014)

Progesterone in the Brain: Hormone, Neurosteroid and Neuroprotectant
por: Guennoun, Rachida
Publicado: (2020)

Brain mineralocorticoid and glucocorticoid receptor balance in neuroendocrine regulation and stress-related psychiatric etiopathologies
por: de Kloet, Edo Ronald
Publicado: (2022)

Behavioral sensitization to cocaine: cooperation between glucocorticoids and epinephrine
por: de Jong, Inge E. M., et al.
Publicado: (2009)

Resetting the Stress System with a Mifepristone Challenge
por: Dalm, Sergiu, et al.
Publicado: (2018)

Early Life Stress Effects on Glucocorticoid—BDNF Interplay in the Hippocampus
por: Daskalakis, Nikolaos P., et al.
Publicado: (2015)

Timing Is Critical for Effective Glucocorticoid Receptor Mediated Repression of the cAMP-Induced CRH Gene
por: van der Laan, Siem, et al.
Publicado: (2009)

Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells
por: Greenstein, Andrew E., et al.
Publicado: (2021)

Long-Term Memory Function Impairments following Sucrose Exposure in Juvenile versus Adult Rats
por: Coirini, Héctor, et al.
Publicado: (2022)

Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials
por: Andrade, Stéphanie, et al.
Publicado: (2023)

Mifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic Depression
por: Block, Thaddeus, et al.
Publicado: (2017)

Glucocorticoid Receptor and Myocyte Enhancer Factor 2 Cooperate to Regulate the Expression of c-JUN in a Neuronal Context
por: Speksnijder, Niels, et al.
Publicado: (2012)

The Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids
por: Oster, Henrik, et al.
Publicado: (2016)

Therapeutic induction of autophagy to modulate neurodegenerative disease progression
por: Hochfeld, Warren E, et al.
Publicado: (2013)

Selective Glucocorticoid Receptor (GR-II) Antagonist Reduces Body Weight Gain in Mice
por: Asagami, Tomoko, et al.
Publicado: (2011)

Fatty Acids: An Insight into the Pathogenesis of Neurodegenerative Diseases and Therapeutic Potential
por: Vesga-Jiménez, Diego Julián, et al.
Publicado: (2022)

Modulation of Mitochondrial Dynamics in Neurodegenerative Diseases: An Insight Into Prion Diseases
por: Zhu, Ting, et al.
Publicado: (2018)

The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications
por: Jain, Arpit, et al.
Publicado: (2023)

Effect of Miricorilant, a Selective Glucocorticoid Receptor Modulator, on Olanzapine-Associated Weight Gain in Healthy Subjects: A Proof-of-Concept Study
por: Hunt, Hazel J., et al.
Publicado: (2021)

A genome-wide signature of glucocorticoid receptor binding in neuronal PC12 cells
por: Polman, J Annelies E, et al.
Publicado: (2012)

Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions
por: Li, Jia-Xu, et al.
Publicado: (2022)

Insights on Glucocorticoid Receptor Activity Modulation through the Binding of Rigid Steroids
por: Presman, Diego M., et al.
Publicado: (2010)

Stress-Induced Enhancement of Mouse Amygdalar Synaptic Plasticity Depends on Glucocorticoid and ß-Adrenergic Activity
por: Sarabdjitsingh, Ratna Angela, et al.
Publicado: (2012)

Antioxidant Therapeutic Strategies in Neurodegenerative Diseases
por: Morén, Constanza, et al.
Publicado: (2022)

Mineralocorticoid receptor and glucocorticoid receptor work alone and together in cell-type-specific manner: Implications for resilience prediction and targeted therapy
por: Daskalakis, Nikolaos P., et al.
Publicado: (2022)

Biomolecular Modulation of Neurodegenerative Events during Ageing
por: Nebbioso, Marcella, et al.
Publicado: (2015)

Expedition into Taurine Biology: Structural Insights and Therapeutic Perspective of Taurine in Neurodegenerative Diseases
por: Bhat, Mujtaba Aamir, et al.
Publicado: (2020)

Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
por: Vuic, Barbara, et al.
Publicado: (2022)

Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacological Effect of Orally Administered CORT125134: An Adaptive, Double‐Blind, Randomized, Placebo‐Controlled Phase 1 Clinical Study
por: Hunt, Hazel, et al.
Publicado: (2017)

Dysfunctional Autophagy and Endolysosomal System in Neurodegenerative Diseases: Relevance and Therapeutic Options
por: Giovedì, Silvia, et al.
Publicado: (2020)

E47 modulates hepatic glucocorticoid action
por: Hemmer, M. Charlotte, et al.
Publicado: (2019)

Novel Therapeutic Opportunities for Neurodegenerative Diseases with Mesenchymal Stem Cells: The Focus on Modulating the Blood-Brain Barrier
por: Vargas-Rodríguez, Pablo, et al.
Publicado: (2023)

Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters
por: Lee, De-Hyung, et al.
Publicado: (2012)

Exploring the Use of Dimethyl Fumarate as Microglia Modulator for Neurodegenerative Diseases Treatment
por: Rosito, Maria, et al.
Publicado: (2020)

Immunomodulation induced by central nervous system‐related peptides as a therapeutic strategy for neurodegenerative disorders
por: Palumbo, María Laura, et al.
Publicado: (2021)

Editorial: Cerebrovascular and Neurodegenerative Diseases - New Insights Into Molecular Cell Biology and Therapeutic Targets
por: Saha, Sikha, et al.
Publicado: (2019)

Editorial: Recording and modulating neural activity in neurodegenerative diseases: Pathophysiological and therapeutic implications
por: Guerra, Andrea, et al.
Publicado: (2023)

Multitarget Therapeutics for Neurodegenerative Diseases
por: Gabr, Moustafa T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jkchlofesf6ujnvrbmmo2u41ai